Focus and Scope

Since 1936 the “Problems of Endocrinology” (or “Problemy Endokrinologii”) Journal has been publishing timely articles, balancing both clinical and experimental research, case reports, reviews and lectures on pressing problems of endocrinology.

The Journal pays special attention to the most relevant issues of endocrinology: to chemical structure, biosynthesis and metabolism of hormones, the mechanism of their action at cellular and molecular level; патогенезу and to clinic of the endocrine diseases, new methods of their diagnostics and treatment. 

The Journal:

  • features original national and foreign research articles, reflecting world endocrinology development;
  • issues thematic editions on specific areas;
  • publishes chronicle of major international congress sessions and workshops on endocrinology, as well as state-of-the-art guidelines;
  • is intended for scientists, endocrinologists, diabetologists and specialists of allied trade, general practitioners, family physicians and pediatrics. 

 

Section Policies

Original Studies

"Problems of Endocrinology" considers all types of original research articles, including experiments conducted in human subjects, laboratory animals, and in vitro.

Specific content areas of interest are as follows: diabetes mellitus, neuroendocrine disorders, endocrine tumors, autoimmune endocrine diseases, epidemiology, pathophysiology, genetics, health services and outcomes research, mineral metabolism, endocrine hypertension, obesity and energy metabolism, personalized medicine, molecular endocrinology, pediatric endocrinology, reproductive health in view of endocrinology, preventive endocrinology, animal models of endocrine diseases, complications of endocrine diseases. The journal publishes results of international and local clinical studies, i.e. observational works. Journal does not publish experimental and clinical studies of dietary supplements. 

Clinical and experimental studies, which are described in the manuscript, must be conducted in accordance with international principles of ethics and deontology. Editorial staff asks the authors to describe the facts that the study was conducted  in accordance with international standard GCP (authors should provide in a manuscript detalized information on voluntary signing of the informed consent of all study participants,  ethics committee evaluation of the study protocol the with the distinct name of ethics committee, the meeting date and protocol number, etc.).

There detailed study protocol should be placed in the "Matherials amd Methods" part of a manuscript. The author should give as many details so that the study can be fully replayed. In the case of meta-analysis the author should describe in detail the procedure of information search and selection: names of databases, filters and keywords.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Reviews

The journal publishes reviews, including systematic reviews of clinical trials in different directions of endocrinology and related areas.

These articles should address a particular question or issue and provide an evidence-based and balanced approach on the focused topic. Controversial aspects and unresolved issues should be discussed. Author should discuss selected data and present the new view on the problem, new approaches to their handling, but not only comleate a declaration of the present problematic status. Thus, the discussion is a mandatory part of the review (it can be isolated in a separate section or place systematically throughout the text). The reviews should include the description of how the relevant evidences were identified, assessed for quality, and selected for inclusion. All the sources of primary information (full-text and abstract databases) should be presented in the manuscript. Also the author should describe in detail the procedure of information search and selection: names of databases, filters and keywords.

The manuscript of review should be structured into sections and contain graphic materials.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Reports

Brief reports usually describe one to three patients or a single family. The text is limited to 2000 words, and up to 20 references. They begin with a brief summary of no more than 150 words.

Potential topics for case reports are:

  • diagnosis: new or rare diseases or unusual presentation of common diseases, uncertain diagnosis, unusual presentation of more common disease, discussion of differential diagnoses, novel diagnostic procedures;
  • treatment: new treatments or established treatments in new situations, treatment of rare diseases, unique technical procedures, unexpected outcomes or effects, adverse events or unanticipated events;
  • special circumstances: highly individualized treatments, complex situations, integration of multiple therapies, ethical challenges, learning from errors, findings that shed new light on the possible pathogenesis of a disease or an adverse effect.

We recommend all authors to hold to manuscript structure and chronologize the facts. Information about a patient should be presented to an expert clinician or clinicians in stages (indicated by boldface type in the manuscript) to simulate the way such information emerges in clinical practice. 

Report common information about the patient’s disease. In case your case reports is devoted to treatment challenge, describe the medication, its indications and usage and potential side effects. A summary of data on the topic may be also presented.

Briefly summarize the background of this case report. Describe the patient characteristics (such as the relevant demographics—age, gender, ethnicity, occupation) and their presenting concerns with relevant details of related past interventions. Also, present the medical, family, and psychosocial history including lifestyle and genetic information, other pertinent co-morbidities and interventions (other therapies including self-care).

Presentation of this case should include the following:

  • symptoms of the disorder;
  • physical examination focused on the important findings including results from testing;
  • diagnostic methods (including laboratory testing, imaging results, questionnaires, referral diagnostic information);
  • diagnostic challenges (such as limited ability to complete an evaluation, patient availability, cultural) and diagnostic reasoning including other diagnoses considered;
  • interventions (such as pharmacologic, surgical, preventive, lifestyle, self-care);
  • administration and intensity of the intervention (including dosage, strength, duration, frequency);
  • prognostic characteristics.

Please describe the strengths and limitations of this case report including case management, and the scientific and medical literature related to this case report. Discuss the rationale for your conclusions such as potential causation and the ways this case might be generalized to a larger population. Finally, what are the main findings of this case report and what are the 'take-away' messages?

 

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of “Problems of Endocrinology”. This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.

  1. Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, deputy editor-in-chief or science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.
  2. Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations: to accept the paper in its present state; to invited the author to revise their manuscript to address specific concerns before final decision is reached; that final decision be reached following further reviewing by another specialist; to reject the manuscript outright.
  3. If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
  4. We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
  5. If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
  6. The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers’ recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
  7. Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
  8. Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
  9. Original reviews of submitted manuscripts remain deposited permanently (not less than 5 years).
  10. Manuscript reviews are not published. Reviews can be sent to the Ministry of Education and Sciense of Russian Federation in case of query.

 

Author Self-Archiving

This journal permits and encourages authors to post items submitted to the journal on personal websites or institutional repositories both prior to and after publication, while providing bibliographic details that credit, if applicable, its publication in this journal.

 

Delayed Open Access

The contents of this journal will be available in an open access format 12 month(s) after an issue is published.

The journal is compliant with Green Open Access mode for articles distribution.

All the articles become Open Access in 12 month after publication.

You can find Open Access articles on the journal's WEB-site and on eLibrary.ru

To get access to new articles within the embargo period you should subscribe to the journal or use eLibrary.ru servise.

 

Indexing

The “Problems of Endocrinology” Journal is included into the “List of leading scientific journals under review, where principal data of applicants for scientific degree has to be published”, as decreed by State Commission for Academic Degrees and Titles in Bulletin №2 of 2003 and revised in 2010.

The journal is indexed in the following international databases and directory editions:

  • SCOPUS 
  • SCIENCE INDEXRussian Scientific Citation Index is a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The SCIENCE INDEX project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
  • Ulrich's Periodicals Directory
  • BIOSIS Previews
  • Google Scholar.

Since 1955 the magazine is the member of the European association of scientific editors (EASE). 

The Journal is registered by Council of ministers of the USSR, the State committee USSR on the press – registration No. 1133 of 07.12.1990.

The Journal is registered by Federal Service for Supervision in the Sphere of Telecom, Information Technologies and Mass Communications – registration № ФС77-36291 from 13.05.2009г.

 

Publishing Ethics

The Ethic policy of "Problems of Endocrinology" journal is based on recomendations from international commettees:

  

 

Reporting standarts

Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.

Only original works are acceptable for publication in "Problems of Endocrinology" journal. The journal does not allow any forms of plagiarism.

If the authors have used the work and/or words of others, that this has been appropriately cited or quoted.

The journal is using "ANTIPLAGIAT" (free edition) software for plagiarism detection in all Russian-language manuscripts. The Google Scholar is used for English-language manuscripts. Papers will be rejected from any stage of the publication process(even if the article were published already) if plagiarism will be fined.

Papers will be rejected from any stage of the publication process (even if the article were publishedalready) if plagiarism will be fined.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

In general, an author should not submit for consideration in another journal a previously published paper. Publication of some kinds of articles (eg, clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at http://www.icmje.org/

Acknowledgement of Sources

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.

The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Statement of Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

----

The page is based on original materials from the Elsevier: http://cdn.elsevier.com/promis_misc/ethicalguidelinesforauthors.pdf

 

Publication Fee

Publication in "Problems of Endocrinology" journal is free for all authors.

The "Problems of Endocrinology" journal charge no publication fees for authors - including those of peer-review management, manuscript processing, journal production, Open-Access, online hosting and archiving.

 

Advertising

"Problems of Endocrinology" journal contain advertisements but advertising is not allowed to influence editorial decisions. Readers will be able to readily distinguish between editorial material and advertising. The juxtaposition of advertisements promoting specific products and scientific articles discussing such products is, as far as possible, avoided. The Editorial Board do not provide unpublished advance information about journal content for forthcoming issues to agencies involved in soliciting advertisements or companies purchasing advertising space. The appearance of any advertisement does not imply warranty, endorsement, or approval of the products or services or of their effectiveness, quality, or safety by the Editorial Board. The Journal has the prerogative to reject any advertisement it deems inappropriate. It accepts advertisements only if the advertisers warrant that the advertisement does not contravene legal requirements on trade descriptions, medicines, race relations, or sex discrimination.